|
CYB5RL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.43739999586879E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75250000067351E-08 |
| Normal-vs-Stage2 |
2.365900E-04 |
| Normal-vs-Stage3 |
1.57445999999783E-05 |
| Normal-vs-Stage4 |
1.625420E-01 |
| Stage1-vs-Stage2 |
6.656000E-01 |
| Stage1-vs-Stage3 |
9.911000E-01 |
| Stage1-vs-Stage4 |
2.896200E-01 |
| Stage2-vs-Stage3 |
6.775600E-01 |
| Stage2-vs-Stage4 |
5.117200E-01 |
| Stage3-vs-Stage4 |
3.148000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.67049999955493E-07 |
| Normal-vs-AfricanAmerican |
1.38700000373859E-08 |
| Normal-vs-Asian |
6.170800E-04 |
| Caucasian-vs-AfricanAmerican |
4.936200E-02 |
| Caucasian-vs-Asian |
1.176570E-01 |
| AfricanAmerican-vs-Asian |
9.014400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.6219999483863E-09 |
| Normal-vs-Female |
1.534300E-02 |
| Male-vs-Female |
8.044300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.04059999999728E-05 |
| Normal-vs-Extreme_Weight |
1.36519999749396E-08 |
| Normal-vs-Obese |
2.38959999999677E-05 |
| Normal-vs-Extreme_Obese |
9.915600E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.287600E-01 |
| Normal_Weight-vs-Obese |
6.674800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.671000E-01 |
| Extreme_Weight-vs-Obese |
5.556400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.766190E-01 |
| Obese-vs-Extreme_Obese |
7.014600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.008100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.72239999998813E-06 |
| Normal-vs-Age(61-80Yrs) |
1.41170000134139E-08 |
| Normal-vs-Age(81-100Yrs) |
1.76802999999337E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.562600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.519400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.912570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.277960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.549640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.492000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.51589909700579E-11 |
| Normal-VS-Type2 PRCC |
1.381720E-04 |
| Normal-VS-KIRP CIMP |
3.476500E-02 |
| Normal-VS-Unclassified PRCC |
1.281770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.057900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.045160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.703500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.649000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.494780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.775600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.03719999991981E-07 |
| Normal-vs-N1 |
4.454200E-02 |
| Normal-vs-N2 |
3.959400E-01 |
| N0-vs-N1 |
1.256650E-01 |
| N0-vs-N2 |
1.770390E-01 |
| N1-vs-N2 |
7.077400E-01 |
|
|
